What is Incyte's D&A?

Incyte (INCY) reported D&A of $26.48M in Q2 2026.

How has Incyte's D&A changed year-over-year?

Incyte's D&A increased by 15.5% year-over-year, from $22.92M to $26.48M.

What is the long-term trend for Incyte's D&A?

Over 4 years (2021 to 2025), Incyte's D&A has grown at a 12.7% compound annual growth rate (CAGR), from $57.84M to $93.29M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Incyte INCY D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.2%

PfizerPFE

$1.61B-0.3%

Celldex TherapeuticsCLDX

$854K-1.5%

GeronGERN

$134K+2.3%

Protagonist TherapeuticsPTGX

$407K+70.3%

Agios PharmaceuticalsAGIO

$1.35M+7.2%

Other financials

Income statement

See full

Revenue$1.7B+37.7%

Gross profit$1.6B+38.0%

Operating income$697.9M+31.6%

Net income$585.6M+44.6%

EPS (diluted)$2.81+37.7%

Balance sheet

See full

Cash & equivalents$4.0B+104%

Total debt$38.3M-9.8%

Total equity$6.3B+52.1%

Total assets$7.9B+35.2%

Cash flow

See full

Operating cash flow$507.7M+1,035%

CapEx$1.6M-43.5%

Free cash flow$509.3M+1,069%

Valuation

See full

Market cap$25.96B+70.1%

Enterprise value$22.01B+64.9%

P/E16.1×-1.4×

P/S4.5×+1.1×

Profitability

See full

Gross margin92.6%-0.3pp

Operating margin30.6%+4.8pp

Net margin27.7%+8.7pp

FCF margin34%+12.3pp

Returns & leverage

See full

Return on equity30.7%+6.4pp

Debt / equity0×0.0×

Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Incyte’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Incyte's D&A?: Incyte (INCY) reported D&A of $26.48M in Q2 2026.
How has Incyte's D&A changed year-over-year?: Incyte's D&A increased by 15.5% year-over-year, from $22.92M to $26.48M.
What is the long-term trend for Incyte's D&A?: Over 4 years (2021 to 2025), Incyte's D&A has grown at a 12.7% compound annual growth rate (CAGR), from $57.84M to $93.29M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.